Amicus Therapeutics vs Novo Nordisk
Amicus Therapeutics vs Novo Nordisk, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Amicus Therapeutics is on 57/100 and Novo Nordisk on 26/100.
Where each one leads
Amicus Therapeutics
- our overall score: 57/100 against 26/100
Novo Nordisk
- agent readiness: 40/100 against 21/100
- domain rating: 80/100 against 66/100
- headcount: 62,380 against 625
- LinkedIn following: 2,840,043 against 57,431
At a glance
| Measure | Amicus Therapeutics | Novo Nordisk |
|---|---|---|
| What it is | Biotechnology company focused on developing treatments for rare metabolic diseases. | Global healthcare company focused on diabetes care, obesity, and rare blood disorders. |
| Category | Biotech, MedTech, HealthTech, Drug Discovery | Biotech, MedTech, HealthTech, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Biotech | Services |
| Founded | 2002 | 1923 |
| Headquarters | Philadelphia, United States | Bagsværd, Denmark |
| Status | Active | Active |
Size, funding and growth
| Measure | Amicus Therapeutics | Novo Nordisk |
|---|---|---|
| Employees | 625 | 62,380 |
| Total funding | $200M | Not published |
| Latest round | Series D | Not published |
| LinkedIn followers | 57,431 | 2,840,043 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Amicus Therapeutics | Novo Nordisk |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 57/100 | 26/100 |
| Traction | 60/100 | 20/100 |
| Team | 30/100 | 10/100 |
| Search visibility | 34/100 | 52/100 |
| Quality | 68/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | D (40/100) |
| Domain ratingLink authority, 0-100 | 66/100 | 80/100 |
What users say
| Measure | Amicus Therapeutics | Novo Nordisk |
|---|---|---|
| Reddit sentimentThreads we track | Not published | 2 positive, 4 negative across 6 threads |
“Novo-Nordisk is the second-largest pharmaceutical company in the diabetes/obesity market, behind competitor Eli Lilly. Its m”r/ValueInvesting
Amicus Therapeutics vs Novo Nordisk: common questions
Which is better, Amicus Therapeutics or Novo Nordisk?
On our 0-100 score Amicus Therapeutics rates higher (57/100 against 26/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do Amicus Therapeutics and Novo Nordisk compare on the numbers?
Amicus Therapeutics leads on our overall score (57/100 against 26/100). Novo Nordisk leads on agent readiness (40/100 against 21/100), domain rating (80/100 against 66/100), headcount (62,380 against 625), LinkedIn following (2,840,043 against 57,431).
What do real users say about Amicus Therapeutics and Novo Nordisk?
Novo Nordisk: 2 positive and 4 negative mentions across 6 Reddit threads we track, mostly in r/ValueInvesting.
Read the full Amicus Therapeutics review and pricing or the Novo Nordisk review and pricing. You can also browse other Amicus Therapeutics alternatives we track.